Generalizable AI predicts immunotherapy outcomes across cancers and treatments - Nature Medicine
2 directory members surfaced this signal.
“Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine https://t.co/Q6UfVQ6wMV”
“🧪 COMPASS, a pan-cancer foundation model, saw n 8.5% average gain in accuracy and 15.7% jump in AUPRC across 16 clinical cohorts. The model routes transcriptomes through 44 biologically grounded immune concepts, helping to predict overall patient survival. …”